ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,796.00
0.34%
S&P ASX All Technology
3,092.40
0.70%
Brent Oil
84.39
0.00%
US Dollar vs AUD
1.49678
0.00%
Bitcoin
64,066.05
-0.28%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Global Cord Blood Corporation (CO)

  7. Global Cord Blood Corporation (CO) News

CO

Global Cord Blood (CO)

Global Cord Blood Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:CO
DateTimeSourceHeadlineSymbolCompany
26/04/202406:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
17/04/202423:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
20/03/202407:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
12/03/202407:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
06/09/202302:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
22/06/202323:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:COGlobal Cord Blood Corporation
03/06/202304:39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
14/04/202305:14PR Newswire (US)GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSNYSE:COGlobal Cord Blood Corporation
14/04/202305:08PR Newswire (US)GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSNYSE:COGlobal Cord Blood Corporation
11/04/202306:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
04/03/202308:20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
04/02/202306:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:COGlobal Cord Blood Corporation
04/02/202300:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:COGlobal Cord Blood Corporation
03/12/202208:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
01/11/202207:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
22/10/202208:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
27/09/202206:07Business WireGlobal Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman IslandsNYSE:COGlobal Cord Blood Corporation
24/09/202204:07TipRanksGlobal Cord Blood trading halted by NYSE for ‘regulatory concern’NYSE:COGlobal Cord Blood Corporation
24/09/202203:52Business WireThe Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
24/08/202223:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:COGlobal Cord Blood Corporation
17/08/202206:26Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:COGlobal Cord Blood Corporation
17/08/202206:16PR Newswire (US)Global Cord Blood Corporation Files Annual Report on Form 20-FNYSE:COGlobal Cord Blood Corporation
02/08/202222:01Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NYSE:COGlobal Cord Blood Corporation
07/07/202206:22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
07/07/202206:16PR Newswire (US)Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGMNYSE:COGlobal Cord Blood Corporation
06/07/202206:16PR Newswire (US)Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022NYSE:COGlobal Cord Blood Corporation
27/06/202222:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
23/06/202206:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:COGlobal Cord Blood Corporation
18/06/202202:49Dow Jones NewsGlobal Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for INDNYSE:COGlobal Cord Blood Corporation
17/06/202206:20PR Newswire (US)Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of MyelofibrosisNYSE:COGlobal Cord Blood Corporation
 Showing the most relevant articles for your search:NYSE:CO

Your Recent History

LSE
ACT
Actual Experience
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved